tmod2 - OmicsDI

Show results for

Unknown (14)
Proteomics (2)

Organisms

Alphavirus (2)
Anemia (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Clostridium perfringens (2)
Cytomegalovirus (2)
Dengue virus (2)
Eukaryota (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Kamptonema sp. (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Pseudomonas aeruginosa (2)
Rattus (2)
Sarbecovirus (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Staphylococcus aureus (2)
Streptococcus pneumoniae (2)
Viruses (2)

Repository

pride (2)

Tissue

Epithelial cell (2)

Disease

Colon cancer (2)

Technology Type

Bottom-up proteomics (2)
Mass Spectrometry (2)
Data-dependent acquisition (1)
Data-independent acquisition (1)

Publication Date

2025 (2)

Release Date

2019 (3)
2018 (3)
2022 (2)
2025 (1)
2023 (1)
2021 (1)
2016 (1)
2014 (1)
2011 (1)

Lab affiliation

Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, Majadahonda, E-28220 Madrid, Spain. (2)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Deciphering the central role of TMOD2 in colorectal cancer progression and metastasis

Tropomodulin-2 (TMOD2) was previously identified as upregulated in the nuclear compartment of highly metastatic KM12SM colorectal cancer (CRC) cells. Here, we aimed to investigate its role using multiple CRC cell lines and patient-derived samples through functional proteomics, bioinformatics, and in...

ORGANISM(S): Homo sapiens (Human)

2025-09-14 | PXD057950 | Pride